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Urinary Retention in Postoperative Patients with Scopolamine Patches
4KS patients with a scopolamine patch were 
experiencing increased length of stay related to urinary 
retention.
• Scopolamine
– An anti-cholinergic often used to prevent post-
operative nausea
– Urinary retention is a known potential side effect
• LVHN Urinary Retention Policy
– Patients have 8 – 10 hours to spontaneously void 
after Foley catheter removal
– If unable to void spontaneously, the patient is straight 
catheterized
– After three straight catheterizations 6-8 hours apart, a 
Foley catheter is placed
• Each time a patient is catheterized, they are made 
susceptible to infection
• Higher perioperative exposure to anti-cholinergic 
medications significantly increases the risk of failed 
postoperative voiding (Walter, Dieter, Siddiqui, 
Weidner, & Wu, 2014)
• Transdermal scopolamine is not a risk factor for acute 
postoperative urinary retention after pelvic 
reconstructive procedures (Propst, O'Sullivan, & 
Tulikangas, 2016)
• In the present large cohort of general surgical patients, 
the prevalence of post-operative urinary retention was 
approximately 5%. (Dreijer, Moller, & Bartholdy, 2011)
• In postoperative patients, how does the use of 
scopolamine patches compared to no scopolamine 
patches affect urinary retention?
– P: postoperative patients
– I: removal of scopolamine patch after first 
catheterization
– C: no patch
– O: decreased urinary retention
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Evidence
Pre-data • Limited sample size for post-data
• Fewer patches were used perioperatively
during post-data collection
Only one patient had experienced post-operative urinary 
retention while wearing a scopolamine patch. The patient 
was catheterized once and the patch was then removed 
15 hours post-operatively. The patient was then able to 
urinate spontaneously and avoid any additional 
catheterizations.  Patient had orders received for 
removal 5 hours after catheterization.
• Nursing staff was educated in person at huddles and 
electronically on the protocol and was involved in 
collecting pre-data and post-data
• Patients who experienced urinary retention while 
wearing a scopolamine patch were recorded
• For post-data collection, an order was obtained from 
the provider to remove the scopolamine patch after 8 
hours of urinary retention in hopes of eliminating the 
need for further catheterizations
• Data was reviewed for effectiveness of intervention
Sample size of patients was 55.  10/55 experienced 
urinary retention
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